First cancer patient dosed in CRISPR-armed phage...
CMN Special
Jun. 12, 2025
Relevant Interviews, Webinar and Trial Updates posted by CRISPR Medicine News.
Always stay updated with the free CMN Newsletter.
Scope Biosciences
Company Type: CRO
Main focus: Molecular diagnostics
Company stage: Actively providing services
Diseases: N/A
Genome-editing tool: Proprietary type III-CRISPR/Cas-platform
Funding stage: Series A
Location: Wageningen, Netherlands
Website: scopebio.com
Scope Bioscience is a Molecular Diagnostics CRO that uses CRISPR to develop kits for the detection of crop infectious species, particularly Tomato rugose fruit virus and Lettuce mosaic virus.
